antineoplaston a10 has been researched along with Hepatocellular Carcinoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hara, H; Iemura, A; Sata, M; Tsuda, H; Uchida, M; Yamana, K | 1 |
Eriguchi, N; Hara, H; Ishii, K; Nishida, H; Sasaki, K; Sugihara, S; Tanaka, N; Tsuda, H; Yoshimura, S | 1 |
Tsuda, H | 1 |
3 other study(ies) available for antineoplaston a10 and Hepatocellular Carcinoma
Article | Year |
---|---|
Inhibitory effect of antineoplaston A10 and AS2-1 on human hepatocellular carcinoma.
Topics: Antineoplastic Agents; Benzeneacetamides; Carcinoma, Hepatocellular; Drug Combinations; Glutamine; Humans; Liver Neoplasms; Phenylacetates; Piperidones; Tumor Cells, Cultured | 1996 |
The inhibitory effect of the combination of antineoplaston A-10 injection with a small dose of cis-diamminedichloroplatinum on cell and tumor growth of human hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Animals; Antineoplastic Combined Chemotherapy Protocols; Benzeneacetamides; Carcinoma, Hepatocellular; Cell Division; Cisplatin; Dose-Response Relationship, Drug; Humans; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Piperidones; Tumor Cells, Cultured | 1992 |
Inhibitory effect of antineoplaston A-10 on breast cancer transplanted to athymic mice and human hepatocellular carcinoma cell lines. The members of Antineoplaston Study Group.
Topics: Administration, Oral; Animals; Benzeneacetamides; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Piperidines; Piperidones; Transplantation, Heterologous; Tumor Cells, Cultured | 1990 |